| 0 |
PLASMODIUM VIVAX INFECTION |
7 |
0.3043 |
| 1 |
SPLEEN PALPABLE |
1 |
0.0130 |
| 2 |
CONJUNCTIVAL PALLOR |
2 |
0.0110 |
| 3 |
METHAEMOGLOBINAEMIA |
20 |
0.0086 |
| 4 |
BILIRUBIN URINE PRESENT |
1 |
0.0084 |
| 5 |
MURDER |
1 |
0.0070 |
| 6 |
HAEMOGLOBIN URINE PRESENT |
1 |
0.0049 |
| 7 |
PERIORBITAL DISORDER |
1 |
0.0049 |
| 8 |
BRONCHOSCOPY |
1 |
0.0042 |
| 9 |
TONGUE SPASM |
1 |
0.0032 |
| 10 |
HAEMOGLOBINURIA |
3 |
0.0027 |
| 11 |
POST THROMBOTIC SYNDROME |
1 |
0.0022 |
| 12 |
INJURY ASPHYXIATION |
1 |
0.0022 |
| 13 |
PO2 INCREASED |
1 |
0.0020 |
| 14 |
CRYSTALLURIA |
1 |
0.0018 |
| 15 |
COMPUTERISED TOMOGRAM THORAX ABNORMAL |
1 |
0.0015 |
| 16 |
MALARIA |
1 |
0.0014 |
| 17 |
BLOOD BILIRUBIN UNCONJUGATED INCREASED |
1 |
0.0014 |
| 18 |
BRAIN STEM SYNDROME |
1 |
0.0013 |
| 19 |
PO2 DECREASED |
1 |
0.0009 |
| 20 |
PNEUMOCYSTIS JIROVECII INFECTION |
1 |
0.0008 |
| 21 |
VESTIBULAR DISORDER |
1 |
0.0008 |
| 22 |
LIP DISCOLOURATION |
1 |
0.0008 |
| 23 |
DRUG CLEARANCE DECREASED |
1 |
0.0008 |
| 24 |
LUNG CONSOLIDATION |
2 |
0.0007 |
| 25 |
CYANOSIS |
8 |
0.0005 |
| 26 |
DENGUE FEVER |
1 |
0.0004 |
| 27 |
GRANULOCYTOPENIA |
2 |
0.0004 |
| 28 |
DYSPNOEA AT REST |
1 |
0.0003 |
| 29 |
HAEMOLYTIC ANAEMIA |
3 |
0.0003 |
| 30 |
CHEST X-RAY ABNORMAL |
1 |
0.0003 |
| 31 |
ORTHOPNOEA |
1 |
0.0003 |
| 32 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
3 |
0.0003 |
| 33 |
TYPE I HYPERSENSITIVITY |
1 |
0.0003 |
| 34 |
DRUG ERUPTION |
5 |
0.0003 |
| 35 |
MACULOPATHY |
1 |
0.0003 |
| 36 |
HYPOPHOSPHATAEMIA |
2 |
0.0003 |
| 37 |
CHROMATURIA |
6 |
0.0003 |
| 38 |
COMMUNICATION DISORDER |
1 |
0.0003 |
| 39 |
HAEMOLYSIS |
2 |
0.0003 |
| 40 |
NAIL DISCOLOURATION |
1 |
0.0003 |
| 41 |
ENURESIS |
1 |
0.0002 |
| 42 |
LIP OEDEMA |
1 |
0.0002 |
| 43 |
DYSPHEMIA |
1 |
0.0002 |
| 44 |
RESPIRATORY RATE INCREASED |
2 |
0.0002 |
| 45 |
LYMPHOPENIA |
3 |
0.0002 |
| 46 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
1 |
0.0002 |
| 47 |
ERYSIPELAS |
1 |
0.0002 |
| 48 |
JAW DISORDER |
1 |
0.0002 |
| 49 |
NEUTROPHILIA |
1 |
0.0002 |
| 50 |
SOCIAL AVOIDANT BEHAVIOUR |
1 |
0.0002 |
| 51 |
GLUCOSE TOLERANCE IMPAIRED |
1 |
0.0002 |
| 52 |
ADRENAL INSUFFICIENCY |
2 |
0.0002 |
| 53 |
INCOHERENT |
1 |
0.0002 |
| 54 |
HAND FRACTURE |
1 |
0.0001 |
| 55 |
POLYURIA |
1 |
0.0001 |
| 56 |
FACE OEDEMA |
2 |
0.0001 |
| 57 |
PURPURA |
1 |
0.0001 |
| 58 |
JAUNDICE |
3 |
0.0001 |
| 59 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 60 |
NEPHROPATHY TOXIC |
1 |
0.0001 |
| 61 |
SPLENOMEGALY |
1 |
0.0001 |
| 62 |
HYPOXIA |
3 |
0.0001 |
| 63 |
HEPATIC FUNCTION ABNORMAL |
3 |
0.0001 |
| 64 |
BRAIN OEDEMA |
1 |
0.0001 |
| 65 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 66 |
DISORIENTATION |
3 |
0.0001 |
| 67 |
DRUG INTERACTION |
12 |
0.0001 |
| 68 |
BLOOD BILIRUBIN INCREASED |
2 |
0.0001 |
| 69 |
TACHYPNOEA |
1 |
0.0001 |
| 70 |
PALLOR |
2 |
0.0001 |
| 71 |
PNEUMONITIS |
2 |
0.0001 |
| 72 |
HYPONATRAEMIA |
4 |
0.0001 |
| 73 |
SKIN REACTION |
1 |
0.0001 |
| 74 |
PULMONARY MASS |
1 |
0.0001 |
| 75 |
TOXIC EPIDERMAL NECROLYSIS |
1 |
0.0001 |
| 76 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 77 |
HYPERKALAEMIA |
2 |
0.0001 |
| 78 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 79 |
ELECTROCARDIOGRAM QT PROLONGED |
2 |
0.0001 |
| 80 |
CHOLESTASIS |
1 |
0.0001 |
| 81 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 82 |
RIB FRACTURE |
1 |
0.0000 |
| 83 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 84 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 85 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 86 |
HYPOKALAEMIA |
2 |
0.0000 |
| 87 |
RESPIRATORY FAILURE |
3 |
0.0000 |
| 88 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 89 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 90 |
SYNCOPE |
4 |
0.0000 |
| 91 |
MOOD ALTERED |
1 |
0.0000 |
| 92 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 93 |
FEELING COLD |
1 |
0.0000 |
| 94 |
PANCYTOPENIA |
2 |
0.0000 |
| 95 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 96 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 97 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 98 |
HEPATIC FAILURE |
1 |
0.0000 |
| 99 |
DISCOMFORT |
2 |
0.0000 |
| 100 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 101 |
EYE DISORDER |
1 |
0.0000 |
| 102 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 103 |
ANGER |
1 |
0.0000 |
| 104 |
NEUTROPENIA |
4 |
0.0000 |
| 105 |
PYREXIA |
10 |
0.0000 |
| 106 |
DELIRIUM |
1 |
0.0000 |
| 107 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 108 |
PANIC ATTACK |
1 |
0.0000 |
| 109 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 110 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 111 |
POLLAKIURIA |
1 |
0.0000 |
| 112 |
DRY SKIN |
3 |
0.0000 |
| 113 |
ARRHYTHMIA |
1 |
0.0000 |
| 114 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 115 |
HEART RATE INCREASED |
2 |
0.0000 |
| 116 |
LEUKOPENIA |
1 |
0.0000 |
| 117 |
AGGRESSION |
1 |
0.0000 |
| 118 |
NERVOUSNESS |
1 |
0.0000 |
| 119 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 120 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 121 |
MEDICATION ERROR |
1 |
0.0000 |
| 122 |
MYALGIA |
3 |
0.0000 |
| 123 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 124 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 125 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 126 |
DECREASED APPETITE |
3 |
0.0000 |
| 127 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 128 |
PRODUCT USE IN UNAPPROVED INDICATION |
3 |
0.0000 |
| 129 |
COMPLETED SUICIDE |
1 |
0.0000 |
| 130 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 131 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 132 |
TACHYCARDIA |
1 |
0.0000 |
| 133 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 134 |
DYSPNOEA |
6 |
0.0000 |
| 135 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 136 |
HYPOTENSION |
2 |
0.0000 |
| 137 |
DRUG INEFFECTIVE |
13 |
0.0000 |
| 138 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 139 |
DEPRESSION |
2 |
0.0000 |
| 140 |
CHILLS |
1 |
0.0000 |
| 141 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 142 |
FEELING ABNORMAL |
2 |
0.0000 |
| 143 |
JOINT SWELLING |
1 |
0.0000 |
| 144 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 145 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 146 |
HEADACHE |
5 |
0.0000 |
| 147 |
RENAL FAILURE |
1 |
0.0000 |
| 148 |
OFF LABEL USE |
6 |
0.0000 |
| 149 |
HOSPITALISATION |
1 |
0.0000 |
| 150 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 151 |
VOMITING |
3 |
0.0000 |
| 152 |
TREMOR |
1 |
0.0000 |
| 153 |
URTICARIA |
1 |
0.0000 |
| 154 |
MUSCLE SPASMS |
1 |
0.0000 |
| 155 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 156 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 157 |
ANAEMIA |
1 |
0.0000 |
| 158 |
ERYTHEMA |
1 |
0.0000 |
| 159 |
DIARRHOEA |
3 |
0.0000 |
| 160 |
OVERDOSE |
1 |
0.0000 |
| 161 |
BACK PAIN |
1 |
0.0000 |
| 162 |
NAUSEA |
3 |
0.0000 |
| 163 |
COUGH |
1 |
0.0000 |
| 164 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 165 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 166 |
ASTHENIA |
1 |
0.0000 |
| 167 |
FATIGUE |
2 |
0.0000 |
| 168 |
MALAISE |
1 |
0.0000 |
| 169 |
DIZZINESS |
1 |
0.0000 |